Literature DB >> 28366822

Quality specifications for the extra-analytical phase of laboratory testing: Reference intervals and decision limits.

Ferruccio Ceriotti1.   

Abstract

Reference intervals and decision limits are a critical part of the clinical laboratory report. The evaluation of their correct use represents a tool to verify the post analytical quality. Four elements are identified as indicators. 1. The use of decision limits for lipids and glycated hemoglobin. 2. The use, whenever possible, of common reference values. 3. The presence of gender-related reference intervals for at least the following common serum measurands (besides obviously the fertility relate hormones): alkaline phosphatase (ALP), alanine aminotransferase (ALT), creatine kinase (CK), creatinine, gamma-glutamyl transferase (GGT), IgM, ferritin, iron, transferrin, urate, red blood cells (RBC), hemoglobin (Hb) and hematocrit (Hct). 4. The presence of age-related reference intervals. The problem of specific reference intervals for elderly people is discussed, but their use is not recommended; on the contrary it is necessary the presence of pediatric age-related reference intervals at least for the following common serum measurands: ALP, amylase, creatinine, inorganic phosphate, lactate dehydrogenase, aspartate aminotransferase, urate, insulin like growth factor 1, white blood cells, RBC, Hb, Hct, alfa-fetoprotein and fertility related hormones. The lack of such reference intervals may imply significant risks for the patients.
Copyright © 2017 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Decision limits; Quality specifications; Reference intervals; Reference values

Mesh:

Substances:

Year:  2017        PMID: 28366822     DOI: 10.1016/j.clinbiochem.2017.03.024

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  2 in total

Review 1.  Errors within the total laboratory testing process, from test selection to medical decision-making - A review of causes, consequences, surveillance and solutions.

Authors:  Cornelia Mrazek; Giuseppe Lippi; Martin H Keppel; Thomas K Felder; Hannes Oberkofler; Elisabeth Haschke-Becher; Janne Cadamuro
Journal:  Biochem Med (Zagreb)       Date:  2020-06-15       Impact factor: 2.313

2.  Development and Validation of Novel Diagnostic Models for Biliary Atresia in a Large Cohort of Chinese Patients.

Authors:  Rui Dong; Jingying Jiang; Shouhua Zhang; Zhen Shen; Gong Chen; Yanlei Huang; Yijie Zheng; Shan Zheng
Journal:  EBioMedicine       Date:  2018-08-01       Impact factor: 8.143

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.